Home Cerus

Cerus

In operation
Post-IPO Round
Blood Products Developer

Basic Information

Cerus Corporation is a biomedical products company focused on the field of blood safety. Cerus currently sells the INTERCEPT Blood System for platelets and plasma in selected countries in Europe, the Commonwealth of Independent States, the Middle East, and other regions around the world. In the United States, Cerus is seeking regulatory approval for its plasma and platelet blood INTERCEPT systems. The INTERCEPT Red Blood Cell system is in clinical development.
Cerus Corporation
California,United States of America
51~100 people
January 01, 2003
--